C07D 213/84
Nitriles
C07D213/84 (Nitriles) appears on 1,109 US grants and 917 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,109
- Published applications
- 917
- Assignees
- 504
- Inventors
- 3,765
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 21 | 0 |
| 1977 | 21 | 0 |
| 1978 | 19 | 0 |
| 1979 | 18 | 0 |
| 1980 | 27 | 0 |
| 1981 | 22 | 0 |
| 1982 | 20 | 0 |
| 1983 | 22 | 0 |
| 1984 | 20 | 0 |
| 1985 | 25 | 0 |
| 1986 | 20 | 0 |
| 1987 | 25 | 0 |
| 1988 | 16 | 0 |
| 1989 | 20 | 0 |
| 1990 | 24 | 0 |
| 1991 | 21 | 0 |
| 1992 | 15 | 0 |
| 1993 | 15 | 0 |
| 1994 | 15 | 0 |
| 1995 | 14 | 0 |
| 1996 | 16 | 0 |
| 1997 | 21 | 0 |
| 1998 | 21 | 0 |
| 1999 | 13 | 0 |
| 2000 | 15 | 0 |
| 2001 | 9 | 5 |
| 2002 | 14 | 14 |
| 2003 | 17 | 31 |
| 2004 | 20 | 60 |
| 2005 | 14 | 36 |
| 2006 | 28 | 47 |
| 2007 | 20 | 48 |
| 2008 | 23 | 41 |
| 2009 | 29 | 34 |
| 2010 | 37 | 39 |
| 2011 | 33 | 28 |
| 2012 | 18 | 21 |
| 2013 | 27 | 29 |
| 2014 | 26 | 44 |
| 2015 | 26 | 31 |
| 2016 | 41 | 35 |
| 2017 | 27 | 47 |
| 2018 | 31 | 31 |
| 2019 | 23 | 32 |
| 2020 | 31 | 33 |
| 2021 | 19 | 38 |
| 2022 | 17 | 35 |
| 2023 | 24 | 56 |
| 2024 | 19 | 44 |
| 2025 | 31 | 37 |
| 2026 | 19 | 21 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Amyloid targeting agents and methods of using the same22 Sep 2026US 12,741,949 B2Amydis, Inc.
- Adenosine 2A receptor modulators for use in the treatment of cancer28 Jul 2026US 12,692,255 B2Universite De Geneve
- Aptamer nucleic acid molecule, and complex and application thereof23 Jun 2026US 12,662,676 B2East China University of Science and Technology
- HSD17B13 inhibitors and uses thereof2 Jun 2026US 12,643,858 B2Inipharm, Inc.
- Heterocyclic compounds as antagonist of NMDA26 May 2026US 12,637,418 B2Takeda Pharmaceutical Company Limited
- Sik2 modulators and uses thereof17 Sep 2026US 2026/0274820 A1Nimbus Salacia, Inc.
- Benzamide compounds for treatment of bacterial infections30 Jul 2026US 2026/0217672 A1Hoffmann-La Roche Inc.
- Protease inhibitors for treating or preventing coronavirus infection23 Jul 2026US 2026/0209180 A1Merck Sharp & Dohme Corp.
- Nitrogen-containing heterocyclic derivative inhibitor, and preparation method therefor and use thereof9 Jul 2026US 2026/0193260 A1Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
- Charged Ion Channel Blockers and Methods for Use30 Apr 2026US 2026/0116859 A1Nocion Therapeutics, Inc.
Most cited
By later US patents
- Certain 7-[2,6-diisopropyl-4-phenyl-5-lower alkoxymethyl-pyrid-3-yl]-3,5-dihydroxy-6-enoates and derivatives useful for treating circulatory diseases116US 5,006,530 ABayer Aktiengesellschaft · 1991
- Processes for preparing dianthranilate compounds and diazopyridone colorants95US 6,576,747 B1Xerox Corporation · 2003
- 2-pyridylmethylamine derivatives useful as fungicides92US 6,503,933 B1Aventis CropScience UK Limited · 2003
- Process for preparing substituted pyridone compounds91US 6,696,552 B2Xerox Corporation · 2004
- Adenosine receptor ligands and their use in the treatment of disease82US 6,586,441 B2Hoffman-La Roche Inc. · 2003